Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Journal of Nanobiotechnology|May 27, 2021
Overcoming chemotherapy resistance using pH-sensitive hollow MnO<sub>2</sub> nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinomaZhi-Hang Zhou, Si-Yuan Liang, Tong-Chao Zhao, et al.Eclinicalmedicine|October 2, 2025
Luvometinib in patients with Langerhans cell histiocytosis, Erdheim-Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 studyXin-Xin Cao, Qi Zhu, Zhen Cai, et al.Oncology Letters|May 8, 2018
Elevated growth differentiating factor 15 expression predicts long-term benefit of docetaxel, cisplatin and 5-fluorouracil induction chemotherapy in patients with oral cancerXiao Tang, Yong-Jie Hu, Wu-Tong Ju, et al.Molecular Cancer Therapeutics|March 22, 2013
Elevated cyclin D1 expression is predictive for a benefit from TPF induction chemotherapy in oral squamous cell carcinoma patients with advanced nodal diseaseLai-Ping Zhong, Dong-Wang Zhu, William N William, et al.Oncotarget|November 7, 2015
Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinomaJie Ma, Xiao Tang, Wen-Wen Sun, et al.Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|September 28, 2020
Diffuse-type tenosynovial giant cell tumor of the temporomandibular joint with skull base invasion: a report of 22 cases with literature reviewYing Liu, Bao-Hua Fan, Yi-Ran Tan, et al.Nature Communications|September 14, 2022
A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinomaWu-Tong Ju, Rong-Hui Xia, Dong-Wang Zhu, et al.Oncotarget|July 1, 2015
Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinomaLai-ping Zhong, Chen-ping Zhang, Guo-xin Ren, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2012
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinomaLai-ping Zhong, Chen-ping Zhang, Guo-xin Ren, et al.The Lancet. Oncology|April 16, 2021
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysisClaire Petit, Benjamin Lacas, Jean-Pierre Pignon, et al.Pageof 9